| Product Code: ETC6736835 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Atherosclerosis Therapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Atherosclerosis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China Atherosclerosis Therapeutics Market - Industry Life Cycle |
3.4 China Atherosclerosis Therapeutics Market - Porter's Five Forces |
3.5 China Atherosclerosis Therapeutics Market Revenues & Volume Share, By Drug Treatment, 2021 & 2031F |
3.6 China Atherosclerosis Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Atherosclerosis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of atherosclerosis in China due to changing lifestyle and dietary habits |
4.2.2 Growing elderly population in China, who are more susceptible to atherosclerosis |
4.2.3 Technological advancements in atherosclerosis therapeutics leading to more effective treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals in China |
4.3.2 High competition among pharmaceutical companies in the atherosclerosis therapeutics market |
4.3.3 Concerns regarding the side effects and safety of atherosclerosis medications |
5 China Atherosclerosis Therapeutics Market Trends |
6 China Atherosclerosis Therapeutics Market, By Types |
6.1 China Atherosclerosis Therapeutics Market, By Drug Treatment |
6.1.1 Overview and Analysis |
6.1.2 China Atherosclerosis Therapeutics Market Revenues & Volume, By Drug Treatment, 2021- 2031F |
6.1.3 China Atherosclerosis Therapeutics Market Revenues & Volume, By Anti-Platelet Medications, 2021- 2031F |
6.1.4 China Atherosclerosis Therapeutics Market Revenues & Volume, By Cholesterol Lowering Medications, 2021- 2031F |
6.1.5 China Atherosclerosis Therapeutics Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.1.6 China Atherosclerosis Therapeutics Market Revenues & Volume, By Angiotensin-Converting Enzyme (ACE) Inhibitors, 2021- 2031F |
6.1.7 China Atherosclerosis Therapeutics Market Revenues & Volume, By Calcium Channel Blockers, 2021- 2031F |
6.1.8 China Atherosclerosis Therapeutics Market Revenues & Volume, By Water Pills, 2021- 2031F |
6.2 China Atherosclerosis Therapeutics Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 China Atherosclerosis Therapeutics Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.2.3 China Atherosclerosis Therapeutics Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.4 China Atherosclerosis Therapeutics Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.2.5 China Atherosclerosis Therapeutics Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.2.6 China Atherosclerosis Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 China Atherosclerosis Therapeutics Market Import-Export Trade Statistics |
7.1 China Atherosclerosis Therapeutics Market Export to Major Countries |
7.2 China Atherosclerosis Therapeutics Market Imports from Major Countries |
8 China Atherosclerosis Therapeutics Market Key Performance Indicators |
8.1 Average patient adherence rate to atherosclerosis therapeutics in China |
8.2 Number of clinical trials for new atherosclerosis treatments in China |
8.3 Percentage of healthcare professionals recommending innovative atherosclerosis therapies |
9 China Atherosclerosis Therapeutics Market - Opportunity Assessment |
9.1 China Atherosclerosis Therapeutics Market Opportunity Assessment, By Drug Treatment, 2021 & 2031F |
9.2 China Atherosclerosis Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Atherosclerosis Therapeutics Market - Competitive Landscape |
10.1 China Atherosclerosis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 China Atherosclerosis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here